Venture
Fisher Wallace Laboratories, Inc.
Latest Form D 2025-06-13- CIK 1787792
- State NY
- Biotechnology
- 2 Form D offerings since 2022-07-26
- Total sold
- $250K
- across 2 offerings
- Rounds
- 2
- Form D offerings since 2022-07-26
- Latest round
- $0
- 2025-06-13 · 021-548894
- Investors
- 0
- on the latest round
Connected
named in its Form D filingsRound timeline
amount sold · by first filed2025-06-13 · $0
- 2022-07-26$250K021-453724
- 2025-06-13$0021-548894
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($250K)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-548894 | First filed2025-06-13 | Latest2025-06-13 | Sought$5M | Sold$0 | Investors0 | Exemptions506(c) |
| 021-453724 | First filed2022-07-26 | Latest2022-07-26 | Sought$750K | Sold$250K | Investors1 | Exemptions506(c) |
Who backs Fisher Wallace Laboratories, Inc., inferred from co-filings, and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2025-06-13
| Name | Relationship |
|---|---|
| Kelly Joseph Roman | RelationshipExecutive Officer, Director |
| Charles Avery Fisher | RelationshipDirector |
Sales compensation
Named in Item 12 of its Form D filings
| Recipient | CRD | Broker-dealer | Offerings |
|---|---|---|---|
| DEALMAKER SECURITIES LLC | CRD315324 | Broker-dealer— | Offerings1 |
Facts
As its latest Form D states them
- Industry
- Biotechnology
- State
- New York (NY)
- Exemptions
- Rule 506(c)
- First filed
- 2022-07-26
- Latest filing
- 2025-06-13
- Minimum investment
- $2.5K
Who backs Fisher Wallace Laboratories, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plans
External link: SEC Filings ↗